Anika TherapeuticsANIK
Market Cap: $364M
About: Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
Employees: 357
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
33% more funds holding in top 10
Funds holding in top 10: 3 [Q1] → 4 (+1) [Q2]
5% less funds holding
Funds holding: 119 [Q1] → 113 (-6) [Q2]
7% less capital invested
Capital invested by funds: $358M [Q1] → $335M (-$23.5M) [Q2]
7.23% less ownership
Funds ownership: 96.3% [Q1] → 89.07% (-7.23%) [Q2]
18% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 49
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
46% less call options, than puts
Call options by funds: $68K | Put options by funds: $127K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Barrington Research Michael Petusky 62% 1-year accuracy 31 / 50 met price target | 51%upside $37 | Outperform Maintained | 9 Aug 2024 |